Full Text
PMU71 EFFECTIVE IMPLEMENTATION OF BIOSIMILAR MEDICINE AT PATENT EXPIRATION TO ACHIEVE OPTIMAL FINANCIAL GAIN: BEST PRACTICE MODEL WITH ADALIMUMAB AS CASE

Abstract

Authors

S. Trolle T.L. Hedegaard

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×